Skip to main content

Advertisement

Log in

The Comparison of the Risk Factors and Clinical Manifestations of Proximal and Distal Colorectal Cancer

  • Original Contributions
  • Published:
Diseases of the Colon & Rectum

Abstract

Purpose

Colorectal cancers in the proximal or distal site have distinct clinical characteristics. In this study, the authors compared the risk factors of proximal and distal colorectal cancer.

Methods

A 16-page questionnaire was administered to 529 patients with colorectal cancer before operation. Cancers were classified as proximal or distal relative to the splenic flexure. Of these 529 patients, 6 patients were excluded because of the presence of synchronous colorectal cancers. Data of the 523 patients were analyzed.

Results

Total numbers of proximal and distal cancers were 123 and 400. The proportion of patients with Type 2 diabetes was significantly higher for distal cancer (P = 0.034), whereas a greater proportion of patients with proximal cancer had a gallstone history (P = 0.005). Multivariate analysis revealed Type 2 diabetes to be a risk factor for distal colorectal cancer (P = 0.027) and cholelithiasis to be a risk factor for proximal cancer (P = 0.049). The odds ratio for distal colorectal cancer among males with Type 2 diabetes was 4.1 (95 percent confidence interval, 1.4–12.1). On the other hand, a gallstone history was more associated with proximal colon cancer, especially in females (odds ratio = 5.5; 95 percent confidence interval, 1.4–20.9).

Conclusions

A comparison of the risk factors of proximal and distal colorectal cancer showed that Type 2 diabetes is associated with distal colorectal cancer in males and that cholelithiasis is associated with proximal colon cancer in females.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bufill JA. Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location. Ann Intern Med 1990;113:779–88.

    PubMed  CAS  Google Scholar 

  2. Pocard M, Salmon RJ, Muleris M, et al. Deux colons–deux cancers? Adenocarcinomes coliques proximal ou distal: arguments en faveur d'une cancerogenese distincte. Bull Cancer 1995;82:10–21.

    PubMed  CAS  Google Scholar 

  3. Distler P, Holt PR. Are right- and left-sided colon neoplasms distinct tumors? Dig Dis 1997;15:302–11.

    Article  PubMed  CAS  Google Scholar 

  4. Gervaz P, Bouzourene H, Cerottini JP, et al. Dukes B colorectal cancer: distinct genetic categories and clinical outcome based on proximal or distal tumor location. Dis Colon Rectum 2001;44:364–73.

    Article  PubMed  CAS  Google Scholar 

  5. Lindblom A. Different mechanisms in the tumorigenesis of proximal and distal colon cancers. Curr Opin Oncol 2001;13:63–9.

    Article  PubMed  CAS  Google Scholar 

  6. Inoue M, Tajima K, Hirose K, et al. Subsite-specific risk factors for colorectal cancer: a hospital-based case-control study in Japan. Cancer Causes Control 1995;6:14–22.

    Article  PubMed  CAS  Google Scholar 

  7. Olschwang S, Hamelin R, Laurent-Puig P, et al. Alternative genetic pathways in colorectal carcinogenesis. Proc Natl Acad Sci U S A 1997;94:12122–7.

    Article  PubMed  CAS  Google Scholar 

  8. Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature 1998;396:643–9.

    Article  PubMed  CAS  Google Scholar 

  9. Azzoni C, Bottarelli L, Campanini N, et al. Distinct molecular patterns based on proximal and distal sporadic colorectal cancer: arguments for different mechanisms in the tumorigenesis. Int J Colorectal Dis 2007;22:115–26.

    Article  PubMed  Google Scholar 

  10. Lynch HT, Watson P, Lanspa SJ, et al. Natural history of colorectal cancer in hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II). Dis Colon Rectum 1988;31:439–44.

    Article  PubMed  CAS  Google Scholar 

  11. Kim DH, Shin MH, Ahn YO. Incidence pattern of colorectal cancer in Korea by subsite of origin. J Korean Med Sci 2000;15:675–81.

    PubMed  CAS  Google Scholar 

  12. Le Marchand L, Wilkens LR, Kolonel LN, Hankin JH, Lyu LC. Associations of sedentary lifestyle, obesity, smoking, alcohol use, and diabetes with the risk of colorectal cancer. Cancer Res 1997;57:4787–94.

    PubMed  Google Scholar 

  13. Yang YX, Hennessy S, Lewis JD. Type 2 diabetes mellitus and the risk of colorectal cancer. Clin Gastroenterol Hepatol 2005;3:587–94.

    Article  PubMed  Google Scholar 

  14. Weiderpass E, Gridley G, Nyren O, Ekbom A, Persson I, Adami HO. Diabetes mellitus and risk of large bowel cancer. J Natl Cancer Inst 1997;89:660–1.

    Article  PubMed  CAS  Google Scholar 

  15. Wideroff L, Gridley G, Mellemkjaer L, et al. Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst 1997;89:1360–5.

    Article  PubMed  CAS  Google Scholar 

  16. Will JC, Galuska DA, Vinicor F, Calle EE. Colorectal cancer: another complication of diabetes mellitus? Am J Epidemiol 1998;147:816–25.

    PubMed  CAS  Google Scholar 

  17. Hu FB, Manson JE, Liu S, et al. Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. J Natl Cancer Inst 1999;91:542–7.

    Article  PubMed  CAS  Google Scholar 

  18. Nilsen TI, Vatten LJ. Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: exploring the hyperinsulinaemia hypothesis. Br J Cancer 2001;84:417–22.

    Article  PubMed  CAS  Google Scholar 

  19. Coughlin SS, Calle EE, Teras LR, Petrelli J, Thun MJ. Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol 2004;159:1160–7.

    Article  PubMed  Google Scholar 

  20. Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM. Fasting serum glucose level and cancer risk in Korean men and women. JAMA 2005;293:194–202.

    Article  PubMed  CAS  Google Scholar 

  21. Larsson SC, Giovannucci E, Wolk A. Diabetes and colorectal cancer incidence in the cohort of Swedish men. Diabetes Care 2005;28:1805–7.

    Article  PubMed  Google Scholar 

  22. Limburg PJ, Anderson KE, Johnson TW, et al. Diabetes mellitus and subsite-specific colorectal cancer risks in the Iowa Women's Health Study. Cancer Epidemiol Biomarkers Prev 2005;14:133–7.

    PubMed  Google Scholar 

  23. Limburg PJ, Vierkant RA, Fredericksen ZS, et al. Clinically confirmed type 2 diabetes mellitus and colorectal cancer risk: a population-based, retrospective cohort study. Am J Gastroenterol 2006;101:1872–9.

    Article  PubMed  Google Scholar 

  24. Giovannucci E. Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr 2001;131:3109S–20S.

    PubMed  CAS  Google Scholar 

  25. Gerich JE. Contributions of insulin-resistance and insulin-secretory defects to the pathogenesis of type 2 diabetes mellitus. Mayo Clin Proc 2003;78:447–56.

    Article  PubMed  Google Scholar 

  26. Bjork J, Nilsson J, Hultcrantz R, Johansson C. Growth-regulatory effects of sensory neuropeptides, epidermal growth factor, insulin, and somatostatin on the non-transformed intestinal epithelial cell line IEC-6 and the colon cancer cell line HT 29. Scand J Gastroenterol 1993;28:879–84.

    Article  PubMed  CAS  Google Scholar 

  27. Tran TT, Medline A, Bruce WR. Insulin promotion of colon tumors in rats. Cancer Epidemiol Biomarkers Prev 1996;5:1013–5.

    PubMed  CAS  Google Scholar 

  28. Tran TT, Gupta N, Goh T, et al. Direct measure of insulin sensitivity with the hyperinsulinemic-euglycemic clamp and surrogate measures of insulin sensitivity with the oral glucose tolerance test: correlations with aberrant crypt foci promotion in rats. Cancer Epidemiol Biomarkers Prev 2003;12:47–56.

    PubMed  CAS  Google Scholar 

  29. Wu Y, Yakar S, Zhao L, Hennighausen L, LeRoith D. Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis. Cancer Res 2002;62:1030–5.

    PubMed  CAS  Google Scholar 

  30. Yang YX, Hennessy S, Lewis JD. Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients. Gastroenterology 2004;127:1044–50.

    Article  PubMed  CAS  Google Scholar 

  31. Wu X, Chen VW, Martin J, et al. Subsite-specific colorectal cancer incidence rates and stage distributions among Asians and Pacific Islanders in the United States, 1995 to 1999. Cancer Epidemiol Biomarkers Prev 2004;13:1215–22.

    Article  PubMed  Google Scholar 

  32. Tricoli JV, Rall LB, Karakousis CP, et al. Enhanced levels of insulin-like growth factor messenger RNA in human colon carcinomas and liposarcomas. Cancer Res 1986;46:6169–73.

    PubMed  CAS  Google Scholar 

  33. Attvall S, Fowelin J, Lager I, Von Schenck H, Smith U. Smoking induces insulin resistance–a potential link with the insulin resistance syndrome. J Intern Med 1993;233:327–32.

    Article  PubMed  CAS  Google Scholar 

  34. Borissova AM, Tankova T, Kirilov G, Dakovska L, Krivoshiev S. The effect of smoking on peripheral insulin sensitivity and plasma endothelin level. Diabetes Metab 2004;30:147–52.

    Article  PubMed  CAS  Google Scholar 

  35. Targher G, Alberiche M, Zenere MB, Bonadonna RC, Muggeo M, Bonora E. Cigarette smoking and insulin resistance in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1997;82:3619–24.

    Article  PubMed  CAS  Google Scholar 

  36. Morimoto LM, Newcomb PA, White E, Bigler J, Potter JD. Variation in plasma insulin-like growth factor-1 and insulin-like growth factor binding protein-3: personal and lifestyle factors (United States). Cancer Causes Control 2005;16:917–27.

    Article  PubMed  Google Scholar 

  37. Wolf LA, Terry PD, Potter JD, Bostick RM. Do factors related to endogenous and exogenous estrogens modify the relationship between obesity and risk of colorectal adenomas in women? Cancer Epidemiol Biomarkers Prev 2007;16:676–83.

    Article  PubMed  CAS  Google Scholar 

  38. Giovannucci E, Colditz GA, Stampfer MJ. A meta-analysis of cholecystectomy and risk of colorectal cancer. Gastroenterology 1993;105:130–41.

    PubMed  CAS  Google Scholar 

  39. Johansen C, Chow WH, Jorgensen T, Mellemkjaer L, Engholm G, Olsen JH. Risk of colorectal cancer and other cancers in patients with gall stones. Gut 1996;39:439–43.

    Article  PubMed  CAS  Google Scholar 

  40. Todoroki I, Friedman GD, Slattery ML, Potter JD, Samowitz W. Cholecystectomy and the risk of colon cancer. Am J Gastroenterol 1999;94:41–6.

    Article  PubMed  CAS  Google Scholar 

  41. Lagergren J, Ye W, Ekbom A. Intestinal cancer after cholecystectomy: is bile involved in carcinogenesis? Gastroenterology 2001;121:542–7.

    Article  PubMed  CAS  Google Scholar 

  42. Schernhammer ES, Leitzmann MF, Michaud DS, et al. Cholecystectomy and the risk for developing colorectal cancer and distal colorectal adenomas. Br J Cancer 2003;88:79–83.

    Article  PubMed  CAS  Google Scholar 

  43. Shao T, Yang YX. Cholecystectomy and the risk of colorectal cancer. Am J Gastroenterol 2005;100:1813–20.

    Article  PubMed  Google Scholar 

  44. Malagelada JR, Go VL, Summerskill WH, Gamble WS. Bile acid secretion and biliary bile acid composition altered by cholecystectomy. Am J Dig Dis 1973;18:455–9.

    Article  PubMed  CAS  Google Scholar 

  45. Narisawa T, Magadia NE, Weisburger JH, Wynder EL. Promoting effect of bile acids on colon carcinogenesis after intrarectal instillation of N-methyl-N'-nitro-N-nitrosoguanidine in rats. J Natl Cancer Inst 1974;53:1093–7.

    PubMed  CAS  Google Scholar 

  46. Koga S, Kaibara N, Takeda R. Effect of bile acids on 1,2-dimethylhydrazine-induced colon cancer in rats. Cancer 1982;50:543–7.

    Article  PubMed  CAS  Google Scholar 

  47. Hepner GW, Hofmann AF, Malagelada JR, Szczepanik PA, Klein PD. Increased bacterial degradation of bile acids in cholecystectomized patients. Gastroenterology 1974;66:556–64.

    PubMed  CAS  Google Scholar 

  48. Roda E, Aldini R, Mazzella G, et al. Enterohepatic circulation of bile acids after cholecystectomy. Gut 1978;19:640–9.

    Article  PubMed  CAS  Google Scholar 

  49. Dunne JR, Gannon CJ, Osborn TM, Taylor MD, Malone DL, Napolitano LM. Preoperative anemia in colon cancer: assessment of risk factors. Am Surg 2002;68:582–7.

    PubMed  Google Scholar 

  50. West DW, Slattery ML, Robison LM, et al. Dietary intake and colon cancer: sex- and anatomic site-specific associations. Am J Epidemiol 1989;130:883–94.

    PubMed  CAS  Google Scholar 

  51. Knekt P, Hakulinen T, Leino A, Heliovaara M, Reunanen A, Stevens R. Serum albumin and colorectal cancer risk. Eur J Clin Nutr 2000;54:460–2.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Young-Ho Kim M.D..

Additional information

Poster presentation at the United European Gastroenterology Week (UEGW), Berlin, German, October 21 to 25, 2006.

About this article

Cite this article

Oh, SW., Kim, YH., Choi, Y.S. et al. The Comparison of the Risk Factors and Clinical Manifestations of Proximal and Distal Colorectal Cancer. Dis Colon Rectum 51, 56–61 (2008). https://doi.org/10.1007/s10350-007-9083-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10350-007-9083-5

Key words

Navigation